GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.
Microbiology Department, Faculty of Medicine, Kuwait University, Jabrya, Kuwait.
J Antimicrob Chemother. 2020 Apr 1;75(Suppl 1):i60-i75. doi: 10.1093/jac/dkaa084.
To determine antibiotic susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolates from community-acquired respiratory tract infections (CA-RTIs) collected in 2015-17 from Kuwait, Lebanon and Saudi Arabia.
MICs were determined by CLSI broth microdilution and susceptibility was assessed using CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
A total of 139 S. pneumoniae isolates were collected from four centres in Kuwait, Lebanon and Saudi Arabia in 2015-17 and 55 H. influenzae isolates were collected and analysed from Saudi Arabia over the same time period. Pneumococci from all three countries were commonly non-susceptible to penicillin based on CLSI oral or low-dose IV penicillin using EUCAST breakpoints (39% in Kuwait to 57.1% in Lebanon) but by CLSI IV and EUCAST high-dose breakpoints most isolates were susceptible (∼90% in Kuwait and Saudi Arabia, and 100% in Lebanon). Isolates from Lebanon were highly susceptible to most other antibiotics (>90%) except cefaclor, oral cefuroxime and cefpodoxime (EUCAST breakpoints only). Overall, susceptibility was significantly lower in Kuwait and Saudi Arabia than Lebanon. Although all H. influenzae isolates (Saudi Arabia only) were β-lactamase negative, 3.6% and 12.7% were ampicillin resistant by CLSI and EUCAST breakpoints, respectively. Otherwise susceptibility was high in H. influenzae. The application of different EUCAST breakpoints for low and higher doses for some of the antibiotics (amoxicillin, amoxicillin/clavulanic acid, ampicillin, penicillin, ceftriaxone, clarithromycin, erythromycin, levofloxacin and trimethoprim/sulfamethoxazole) allowed, for the first time in a SOAR study, the effect of raising the dosage on susceptibility to be quantified.
Relatively low antibiotic susceptibility was observed in S. pneumoniae from Kuwait and Saudi Arabia in contrast to Lebanon, where rates of susceptibility were generally higher. Isolates of H. influenzae from Saudi Arabia were susceptible to most antibiotics. These factors are important in decision making for empirical therapy of CA-RTIs.
确定 2015-2017 年在科威特、黎巴嫩和沙特阿拉伯采集的社区获得性呼吸道感染(CA-RTI)分离的肺炎链球菌和流感嗜血杆菌的抗生素敏感性。
采用 CLSI 肉汤微量稀释法测定 MIC,并采用 CLSI、EUCAST(剂量特异性)和药代动力学/药效学(PK/PD)折点评估敏感性。
2015-2017 年,从科威特、黎巴嫩和沙特阿拉伯的四个中心共采集了 139 株肺炎链球菌,同期还从沙特阿拉伯采集并分析了 55 株流感嗜血杆菌。来自这三个国家的肺炎球菌根据 CLSI 口服或低剂量 IV 青霉素的 EUCAST 折点,通常对青霉素不敏感(科威特为 39%,黎巴嫩为 57.1%),但根据 CLSI IV 和 EUCAST 高剂量折点,大多数分离株是敏感的(科威特和沙特阿拉伯约为 90%,黎巴嫩为 100%)。来自黎巴嫩的分离株对大多数其他抗生素(>90%)高度敏感,除头孢克洛、口服头孢呋辛和头孢泊肟(仅 EUCAST 折点)外。总体而言,科威特和沙特阿拉伯的敏感性明显低于黎巴嫩。虽然所有流感嗜血杆菌分离株(仅来自沙特阿拉伯)均为β-内酰胺酶阴性,但根据 CLSI 和 EUCAST 折点,分别有 3.6%和 12.7%的分离株对氨苄西林耐药。否则,流感嗜血杆菌的敏感性较高。在某些抗生素(阿莫西林、阿莫西林/克拉维酸、氨苄西林、青霉素、头孢曲松、克拉霉素、红霉素、左氧氟沙星和甲氧苄啶/磺胺甲噁唑)中应用不同的 EUCAST 低剂量和高剂量折点,首次在 SOAR 研究中量化了提高剂量对敏感性的影响。
与黎巴嫩相比,科威特和沙特阿拉伯的肺炎链球菌的抗生素敏感性相对较低,而黎巴嫩的敏感性普遍较高。来自沙特阿拉伯的流感嗜血杆菌分离株对大多数抗生素敏感。这些因素对于社区获得性呼吸道感染的经验性治疗决策非常重要。